Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review

IMPORTANCE: For nearly a century, no generic form of insulin has been available in the United States. However, the first biosimilar insulin, Basaglar, was approved by the U.S. Food and Drug Administration in 2015, and subsequently Admelog and Lusduna in 2017. OBJECTIVE: To summarize the scientific e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tieu, Carolyn, Lucas, Eleanor J., DePaola, Mindi, Rosman, Lori, Alexander, G. Caleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905882/
https://www.ncbi.nlm.nih.gov/pubmed/29668697
http://dx.doi.org/10.1371/journal.pone.0195012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905882/
https://www.ncbi.nlm.nih.gov/pubmed/29668697
http://dx.doi.org/10.1371/journal.pone.0195012

Ejemplares similares